Pharmafile Logo

Asymptote

Cook Regentec and Asymptote Introduce the CellSeal Automated Thawing System

Indianapolis, US, and Cambridge UK, 29th November 2016: Cook Regentec, focused on developing research and clinical tools to advance regenerative medicine therapies from the lab to the patient, and Asymptote Ltd, specialists in cryochain for regenerative medicine, today announced the launch of the CellSeal Automated Thawing System. The new system, which has been developed as...

Asymptote introduces the my.Cryochain software platform to control the cryogenic cold chain for cellular therapies

Cambridge UK, 28th November 2016: Asymptote Ltd, specialists in cryochain technology for advanced medicines, today announced the commercial launch of my.Cryochain, a software platform developed specifically to give centralized control of the cryogenic cold chain for cellular therapies. As production of cellular therapies scales from clinical trials to market authorization and beyond, manufacturing companies and...
https://asymptote.co.uk/
info@asymptote.co.uk
Asymptote Ltd, St. Johns Innovation Centre, Cowley Road, Cambridge, CB4 0WS, UK

+44(0)1223 421161